Get 50% OFF This Summer!
Albert David
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'. The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.
ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital.
ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.
During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECAR,NIMERIL-T,EVICT,ALROF-50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.
New products were launched such as - INTECAR Capsules, NIMERIL-T, EVICT, ALROF-50, ADLIN and SLOZIN during the year 2003; new products such as Alamin-FeZ and Pansure were introduced in 2004. SIOOXY (Anti-Oxidant with OMEGA-3 Fatty Acid) was launched in 2005, launched ALAMTN-Xtra, VERBET - the antivertigo drug and water for injection during year 2006; launched Antibiotic Azithromycin under brand 'AZ3' and expanded its Vision Care range (launched Antiglaucoma products, Antiinfectives, Irrigating Solution and Steroidal combinations) in 2009; launched uterine tonic-Siocare and Laxative combination-Evict Fibre and has also expanded its Anti-inflammatory & Analgesic range with launch of Anaflam XP in 2010; launched Rabeprazole and its combination (Anti-Peptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013; launched Alamin Liquid and Alamin RLD (L-Arginine Sachet) in 2014; launched Dhup Tab & Drop (Vit.D3), Inbalanse-Z (probiotic) and Evict-XF (Laxative) in 2015; launched Sioneuron M/PG capsules, Inbalanse-Z capsules and Breaze-Fx tablet in 2017. It introduced two products i.e., Evacure and C3H in the market during year 2021-22.
Albert David share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Albert David indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Albert David is valued compared to its competitors.
Albert David PE ratio helps investors understand what is the market value of each stock compared to Albert David 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Albert David evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Albert David generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Albert David in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Albert David shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Albert David compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Albert David over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Albert David helps investors get an insight into when they can enter or exit the stock. Key components of Albert David Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Albert David shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Albert David ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Albert David provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Albert David highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Albert David .
The balance sheet presents a snapshot of Albert David ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App